Detection of oncogenic and clinically actionable mutations in cancer genomes critically depends on variant calling tools BIOINFORMATICS
Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial BLOOD
Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q EBIOMEDICINE
Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications? CARDIOVASC DRUG THER
Ocular involvement in patients with primary central-nervous-system lymphoma: Analysis of a multicentre study in Spain BRIT J HAEMATOL
Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry CANCERS